Ramaswamy, A., Ostwal, V., Sharma, A., Bhargava, P., Srinivas, S., Goel, M., . . . Gupta, S. (2020). Efficacy of Capecitabine Plus Irinotecan vs Irinotecan Monotherapy as Second-line Treatment in Patients With Advanced Gallbladder Cancer: A Multicenter Phase 2 Randomized Clinical Trial (GB-SELECT). JAMA Oncol.
Citación estilo ChicagoRamaswamy, Anant, et al. "Efficacy of Capecitabine Plus Irinotecan Vs Irinotecan Monotherapy As Second-line Treatment in Patients With Advanced Gallbladder Cancer: A Multicenter Phase 2 Randomized Clinical Trial (GB-SELECT)." JAMA Oncol 2020.
Cita MLARamaswamy, Anant, et al. "Efficacy of Capecitabine Plus Irinotecan Vs Irinotecan Monotherapy As Second-line Treatment in Patients With Advanced Gallbladder Cancer: A Multicenter Phase 2 Randomized Clinical Trial (GB-SELECT)." JAMA Oncol 2020.